Does TALQUETAMAB-TGVS Cause Onychomadesis? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Onychomadesis have been filed in association with TALQUETAMAB-TGVS. This represents 5.6% of all adverse event reports for TALQUETAMAB-TGVS.
46
Reports of Onychomadesis with TALQUETAMAB-TGVS
5.6%
of all TALQUETAMAB-TGVS reports
0
Deaths
4
Hospitalizations
How Dangerous Is Onychomadesis From TALQUETAMAB-TGVS?
Of the 46 reports, 4 (8.7%) required hospitalization.
Is Onychomadesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALQUETAMAB-TGVS. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does TALQUETAMAB-TGVS Cause?
Cytokine release syndrome (162)
Ageusia (88)
Weight decreased (74)
Dysgeusia (73)
Skin exfoliation (65)
Immune effector cell-associated neurotoxicity syndrome (55)
Dry mouth (53)
Off label use (51)
Rash (48)
Nail disorder (45)
What Other Drugs Cause Onychomadesis?
ADALIMUMAB (797)
METHOTREXATE (785)
RITUXIMAB (722)
TOCILIZUMAB (721)
ABATACEPT (703)
INFLIXIMAB (682)
SECUKINUMAB (678)
LEFLUNOMIDE (667)
GOLIMUMAB (660)
HYDROXYCHLOROQUINE (660)
Which TALQUETAMAB-TGVS Alternatives Have Lower Onychomadesis Risk?
TALQUETAMAB-TGVS vs TAMIFLU
TALQUETAMAB-TGVS vs TAMOXIFEN
TALQUETAMAB-TGVS vs TAMSULOSIN
TALQUETAMAB-TGVS vs TAPENTADOL
TALQUETAMAB-TGVS vs TAPINAROF